3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
298
Sarcoma
79
Gastrointestinal
20
Lymphoid
17
Genitourinary
16
Myeloid
13
Head & Neck
7
Thoracic
6
Endocrine
6
Dermatologic
5
Other solid neoplasm
3
Other hematologic neoplasm
3
Plasma cell
2
Gynecologic
2
Breast
2
NET
1
Classical hematology
1
Conditions
Neuroendocrine Tumors
169
Carcinoid Tumor
27
Carcinoma, Neuroendocrine
22
Neoplasms
16
Gastro-enteropancreatic neuroendocrine tumor
16
Adenoma, Islet Cell
15
Pancreatic Neoplasms
12
Neoplasm Metastasis
10
Pheochromocytoma
8
Paraganglioma
8
Sarcoma
7
Colorectal Neoplasms
7
Carcinoma
7
Neuroectodermal Tumors, Primitive
6
Neuroblastoma
6
Gastrointestinal Neoplasms
6
Vipoma
5
Somatostatinoma
5
Gastrinoma
5
Cholangiocarcinoma
5
Carcinoma, Islet Cell
5
Breast Neoplasms
5
Small Cell Lung Carcinoma
4
Serotonin Syndrome
4
Digestive System Neoplasms
4
Anus Neoplasms
4
Thyroid Neoplasms
3
Salivary Gland Neoplasms
3
Ovarian Neoplasms
3
Neoplasms by Site
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Glioma
×
NET
×
Clear all
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled